Send the following on WhatsApp
Continue to Chathttps://www.marketscreener.com/quote/stock/BIOCRYST-PHARMACEUTICALS--8534/news/BioCryst-Receives-Health-Canada-Approval-for-RAPIVAB-for-the-Treatment-of-Influenza-23661522/?utm_source=whatsapp&utm_medium=social&utm_campaign=share